In a recent Swedish registry study, fracture risk was higher in patients who were on insulin treatment, with low physical activity, a body mass index (BMI) below 25 kg m−2, and long‐standing disease duration but lower in most (55%) individuals with T2D than in age‐ and sex‐matched background population.(8) Other factors are also considered to increase fracture risk in T2D, including increased risk of falls, poor glycemic control, and diabetes complications, including MVD.(9). The gene discussed is INS; the disease is type 2 diabetes mellitus.